Literature DB >> 18837640

Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.

John Mendelson1, Keith Flower, Mark J Pletcher, Gantt P Galloway.   

Abstract

Dependence on and abuse of prescription opioid drugs is now a major health problem, with initiation of prescription opioid abuse exceeding cocaine in young people. Coincident with the emergence of abuse and dependence on prescription opioids, there has been an increased emphasis on the treatment of pain. Pain is now the "5th vital sign" and physicians face disciplinary action for failure to adequately relieve pain. Thus, physicians are whipsawed between the imperative to treat pain with opioids and the fear of producing addiction in some patients. In this article, the authors characterize the emerging epidemic of prescription opioid abuse, discuss the utility of buprenorphine in the treatment of addiction to prescription opioids, and present illustrative case histories of successful treatment with buprenorphine. Copyright (c) 2008 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18837640      PMCID: PMC4687728          DOI: 10.1037/a0013637

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  39 in total

Review 1.  Prescription drug abuse. A question of balance.

Authors:  T Parran
Journal:  Med Clin North Am       Date:  1997-07       Impact factor: 5.456

2.  Characterizing the emerging population of prescription opioid abusers.

Authors:  Stacey C Sigmon
Journal:  Am J Addict       Date:  2006 May-Jun

3.  Availability of addiction medications in private health plans.

Authors:  Constance M Horgan; Sharon Reif; Dominic Hodgkin; Deborah W Garnick; Elizabeth L Merrick
Journal:  J Subst Abuse Treat       Date:  2007-05-17

4.  Withdrawal from methadone maintenance. Impact of a tapering network support program.

Authors:  J L Sorensen; M Trier; S Brummett; M L Gold; R Dumontet
Journal:  J Subst Abuse Treat       Date:  1992

5.  Prescription opioid abuse among enrollees into methadone maintenance treatment.

Authors:  Andrew Rosenblum; Mark Parrino; Sidney H Schnoll; Chunki Fong; Carleen Maxwell; Charles M Cleland; Stephen Magura; J David Haddox
Journal:  Drug Alcohol Depend       Date:  2007-03-26       Impact factor: 4.492

6.  Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

Authors:  Ira L Mintzer; Mark Eisenberg; Maria Terra; Casey MacVane; David U Himmelstein; Steffie Woolhandler
Journal:  Ann Fam Med       Date:  2007 Mar-Apr       Impact factor: 5.166

7.  Methadone medical maintenance in primary care. An implementation evaluation.

Authors:  Joseph O Merrill; T Ron Jackson; Beryl A Schulman; Andrew J Saxon; Asaad Awan; Sonja Kapitan; Molly Carney; Lyndia C Brumback; Dennis Donovan
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

Review 8.  Opioid dependence and addiction during opioid treatment of chronic pain.

Authors:  Jane C Ballantyne; Steven K LaForge
Journal:  Pain       Date:  2007-05-04       Impact factor: 6.961

9.  Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers.

Authors:  Mark K Greenwald; Chris-Ellyn Johanson; David E Moody; James H Woods; Michael R Kilbourn; Robert A Koeppe; Charles R Schuster; Jon-Kar Zubieta
Journal:  Neuropsychopharmacology       Date:  2003-11       Impact factor: 7.853

10.  Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.

Authors:  Brent A Moore; David A Fiellin; Declan T Barry; Lynn E Sullivan; Marek C Chawarski; Patrick G O'Connor; Richard S Schottenfeld
Journal:  J Gen Intern Med       Date:  2007-04       Impact factor: 5.128

View more
  21 in total

1.  Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; David A Fiellin; Marilyn Byrne; Hilary S Connery; William Dickinson; John Gardin; Margaret L Griffin; Marc N Gourevitch; Deborah L Haller; Albert L Hasson; Zhen Huang; Petra Jacobs; Andrzej S Kosinski; Robert Lindblad; Elinore F McCance-Katz; Scott E Provost; Jeffrey Selzer; Eugene C Somoza; Susan C Sonne; Walter Ling
Journal:  Arch Gen Psychiatry       Date:  2011-11-07

2.  Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes.

Authors:  Carrie German; Minu Pilvankar; Andrzej Przekwas
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-08-08       Impact factor: 2.745

3.  Manual therapists - Have you lost that loving feeling?!

Authors:  Paul E Mintken; Jason Rodeghero; Joshua A Cleland
Journal:  J Man Manip Ther       Date:  2018-03-26

4.  A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; Scott E Provost; Zhen Huang; Petra Jacobs; Albert Hasson; Robert Lindblad; Hilary Smith Connery; Kristi Prather; Walter Ling
Journal:  Contemp Clin Trials       Date:  2010-01-29       Impact factor: 2.226

5.  Primary care physicians' perspectives on Veterans who obtain prescription opioids from multiple healthcare systems.

Authors:  Felicia R Bixler; Thomas R Radomski; Susan L Zickmund; KatieLynn M Roman; Leslie R M Hausmann; Carolyn T Thorpe; Jennifer A Hale; Florentina E Sileanu; Walid F Gellad
Journal:  J Opioid Manag       Date:  2019 May/Jun

6.  Subtypes of nonmedical opioid users: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Dan G Blazer
Journal:  Drug Alcohol Depend       Date:  2010-07-01       Impact factor: 4.492

Review 7.  Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?

Authors:  D Andrew Tompkins; Claudia M Campbell
Journal:  Curr Pain Headache Rep       Date:  2011-04

8.  Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats.

Authors:  M D Raleigh; M Pravetoni; A C Harris; A K Birnbaum; P R Pentel
Journal:  J Pharmacol Exp Ther       Date:  2012-12-07       Impact factor: 4.030

9.  Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy.

Authors:  Nancy M Petry; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2013-03-25

Review 10.  Dependence on Prescription Opioids.

Authors:  Johannes Just; Martin Mücke; Markus Bleckwenn
Journal:  Dtsch Arztebl Int       Date:  2016-04-01       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.